OVID — Ovid Therapeutics Inc

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates OVID Bullish with a Setup Score of 77, net conviction 51, actionability 117. How the Setup Score works →

Total Setup Score77
Directional BiasBullish
Net Conviction51
Actionability117 (in range)

Key signals behind this score

About Ovid Therapeutics Inc

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activa… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$2.54
Market Cap$463M
Float156.8M
Shares Outstanding188.7M
P/E (Forward)1.79
Price/Sales (TTM)318.39
vs. Analyst Target+142.1% to analyst PT
Operating Margin (TTM)-4693.74%
Revenue (TTM)$1.5M
Dividend RateNone
Analyst Target Price$6.15 (13 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $12.6M -$80.7M $12.6M -$81.1M
2021 $208M $123M $208M $124M
2022 $1.5M -$51.4M $1.5M -$54.2M
2023 $392,000 -$52.3M $392,000 -$57.0M
2024 $566,000 -$26.4M $566,000 -$57.8M
2025 $7.3M -$17.4M $7.0M -$17.1M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Dec 2025 $718,000 $9.7M
Mar 2026 N/A -$17.0M
Jun 2026 $733,000 -$15.0M
Sep 2026 N/A -$20.8M

Ownership & Float

Insider Ownership7.0%
Institutional Ownership85.3%
Short Float11.6%
% of All Funds Holding1.46%
Number of Funds Holding130

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$2.49Near-term / short-term trend
Weekly40-Week SMA$2.44Medium-term trend
Weekly80-Week SMA$1.77Cyclical trend (business cycle)
Weekly200-Week SMA$2.11Secular trend (multi-year)
Monthly10-Month SMA$2.45Near-term monthly trend
Monthly20-Month SMA$1.74Medium-term monthly trend
Monthly40-Month SMA$1.93Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$2.20 support 1.17x 6 months ago
$1.60 support 2.07x 7 months ago
$0.50 support 2.09x 14 months ago
$0.40 support 3.68x 15 months ago

Historical Earnings Reactions (38 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.15% 0.00% 42.11% 6.99% -28.02%
1 Day 0.60% -0.22% 47.37% 56.86% -28.02%
1 Week 2.90% 0.00% 43.24% 73.67% -24.82%
2 Weeks 9.50% 1.28% 54.05% 130.35% -33.81%
1 Month 6.32% 1.50% 51.35% 134.00% -75.54%

Next earnings: January 29, 2027 (74 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan2.1%44.4%9
Feb-6.6%33.3%9
Mar0.2%44.4%9
Apr13.4%66.7%9
May-4.1%33.3%9
Jun-0.5%40.0%10
Jul7.3%50.0%10
Aug12.9%40.0%10
Sep5.9%40.0%10
Oct-8.7%30.0%10
Nov22.9%66.7%9
Dec-16.2%22.2%9

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.10% 47.0% 449
Tuesday 0.25% 47.2% 492
Wednesday 0.16% 47.0% 489
Thursday -0.13% 44.1% 481
Friday 0.30% 44.4% 480

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 85.3%

Insider Transactions — Smart Summary

Total insider ownership: 7.0%

Founder-led management: Jeremy Levin (Executive Chairman)

12-Month Insider Activity Summary

Total Filings2
Net Value-$29,285.65
Net Shares Change47,928
% of Float0.0%
C-Suite Filings2
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
ALEXANDER MARGARET A. President and CEO -$16,901.2 1 N/A
Rona Jeffrey A CBFO -$12,384.45 1 N/A

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-02 Rona Jeffrey A CBFO -$12,384.45 Transaction at $1.45, now +75.2%
2026-03-02 ALEXANDER MARGARET A. President and CEO -$16,901.2 Transaction at $1.45, now +75.2%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Ovid Therapeutics Inc (OVID) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for OVID on Trend Edge →